Products - Diabetes | Topic

Showing 20 products

Date | Sort by Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
Status: In developmentRemove ‘Status: In development’ filter

Diabetes (type 1 and type 2) in children and young people: diagnosis and management – periodontal disease
Status:
In development
Programme:
NICE guideline
Expected publication date:
29 June 2022
Type 1 diabetes in adults: diagnosis and management – periodontal disease
Status:
In development
Programme:
NICE guideline
Expected publication date:
29 June 2022
Type 2 diabetes in adults: management - periodontal disease
Status:
In development
Programme:
NICE guideline
Expected publication date:
29 June 2022
Finerenone for treating chronic kidney disease in people with type 2 diabetes [ID3773]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
6 June 2022
Expected publication date:
14 September 2022
Brolucizumab for treating diabetic macular oedema [ID3902]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
16 November 2022
Diabetic foot problems: prevention and management (update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
18 January 2023
Diabetes (type 1 and type 2) in children and young people: diagnosis and management - medicines for type 2 diabetes (update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
3 January 2024
Diabetic retinopathy
Status:
In development
Programme:
NICE guideline
Expected publication date:
3 April 2024
Diabetic retinopathy - ruboxistaurin [ID382]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Macular oedema (diabetic) - pegaptanib sodium [ID452]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Diabetes - buccal insulin [ID311]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Empagliflozin for reducing the risk of cardiovascular events in type 2 diabetes [ID1037]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Empagliflozin for type 1 Diabetes Mellitus, adjunct to insulin ID1275
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Ticagrelor for preventing cardiovascular events in people with type 2 diabetes and coronary artery disease [ID1514]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Diabetes update
Status:
In development
Programme:
NICE guideline
Expected publication date:
TBC
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Faricimab for treating diabetic macular oedema [ID3899]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tirzepatide for treating type 2 diabetes ID3938
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Type 2 diabetes in adults: management (medicines update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
TBC

Diabetes Products

Filter

Product type
1 selected

Guidance programme

Status
1 selected

New and updated

Showing 20 products

Diabetes (type 1 and type 2) in children and young people: diagnosis and management – periodontal disease

Type 1 diabetes in adults: diagnosis and management – periodontal disease

Type 2 diabetes in adults: management - periodontal disease

Finerenone for treating chronic kidney disease in people with type 2 diabetes [ID3773]

Brolucizumab for treating diabetic macular oedema [ID3902]

Diabetic foot problems: prevention and management (update)

Diabetes (type 1 and type 2) in children and young people: diagnosis and management - medicines for type 2 diabetes (update)

Diabetic retinopathy

Diabetic retinopathy - ruboxistaurin [ID382]

Macular oedema (diabetic) - pegaptanib sodium [ID452]

Diabetes - buccal insulin [ID311]

Empagliflozin for reducing the risk of cardiovascular events in type 2 diabetes [ID1037]

Empagliflozin for type 1 Diabetes Mellitus, adjunct to insulin ID1275

Ticagrelor for preventing cardiovascular events in people with type 2 diabetes and coronary artery disease [ID1514]

Diabetes update

Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]

Faricimab for treating diabetic macular oedema [ID3899]

Tirzepatide for treating type 2 diabetes ID3938

Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes

Type 2 diabetes in adults: management (medicines update)

Diabetes Products

Filter

Product type1 selected

Guidance programme

Status1 selected

New and updated

Showing 20 products

Product type
1 selected

Status
1 selected